Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19
NCT04345406
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
COVID
Interventions
DRUG:
ACEIs
DRUG:
Conventional treatment
Sponsor
Tanta University